2M6

Medtronic PLC

Healthcare · EUR · F

2M6

Price

€67.128

+0.64%

Cap

€87.77B

Earnings

30d Trend

-5.4%

2M6
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

21% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level42
Quality62
Momentum35
Technical40
Fundamentals51

Raw weighted: 49×Macro 0.99 (1%)=49

RISK

42/100
90d Volatility
21.1%Moderate
ATR %
2.2%Normal
Max Drawdown (1Y)
-28.1%Normal

QUALITY

62/100
ROE (avg)
9.7%Weak
Piotroski F-Score
7/9Strong
Debt/Equity
0.53Moderate
Margin Stability
CV 17.8%Volatile
Accruals
-2.6%Cash earnings
Interest Coverage
8.3xAdequate

MOMENTUM

35/100
12-1M Momentum
-0.6%Downtrend
6-1M Momentum
-22.3%Negative
1M Return
-4.8%Recent pullback

TECHNICAL

40/100
RSI (14)
35.4Neutral
Price vs SMA200
-17.7%Bearish trend
MACD
+0.26Bullish momentum
Bollinger Band
18%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.194Noisy/choppy

FUNDAMENTALS

51/100
EV/EBIT
22.3Fair
P/FCF
21.8Fair
P/S
3.4Fair
PEG
4.53Overpriced growth
Shareholder Yield
6.0%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months50
3-12 months26
1-5+ years58

Long-term compounder with 6.0% yield

BRAIN47'S ASSESSMENT

I rate Medtronic PLC at 49/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 62/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-4.8%

3 MONTHS

-22.0%

12 MONTHS

-5.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 6.0% yield. Quality (62) and low-risk profile are the primary strengths. I note that momentum is the weakest area at 35/100 — this warrants monitoring. Historical volatility is normal at 21%. I classify this as an income position — the 6.0% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 49/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.